Found 22 Acute Myeloid Leukemia trials
A listing of Acute Myeloid Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purposes of this study are to see if the study drugs, venetoclax and gilteritinib can be safely and effectively combined for the treatment of patients with acute myeloid leukemia (AML) that has returned after prior treatment, or has failed to respond to prior treatment and identify potential biomarkers.
This study is evaluating the safety and efficacy of UCART targeting CD123 in patients with relapsed/refractory acute myeloid leukemia (AML). The purpose of this study is to evaluate the safety and clinical activity of UCART123v1.2 and determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D).
Amphivena Therapeutics, Inc. (Amphivena) is studying an investigational drug called AMV564, which may help to treat acute myeloid leukemia (AML). The purpose of this clinical research study is to find the highest tolerable dose that can be given to patients with AML, and to recommend a dose to be used …
See protocol section 2 See protocol section 2 See protocol section 4
See protocol section 2 See protocol section 2 See protocol section 4
TX Study See protocol section 2 See protocol section 2 See protocol section 4
TX Study See protocol section 2 See protocol section 2 See protocol section 4
TX Study See protocol section 2 See protocol section 2 See protocol section 4
TX Study See protocol section 2 See protocol section 2 See protocol section 4
TX Study See protocol section 2 See protocol section 2 See protocol section 4
